The global Human Microbiome Sequencing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The publisher report includes an overview of the development of the Human Microbiome Sequencing industry chain, the market status of Genome Analysis (Next-Generation Sequencing, Traditional Sequencing Technologies), Metabolome Analysis (Next-Generation Sequencing, Traditional Sequencing Technologies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Microbiome Sequencing.
Regionally, the report analyzes the Human Microbiome Sequencing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Microbiome Sequencing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Microbiome Sequencing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Microbiome Sequencing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Next-Generation Sequencing, Traditional Sequencing Technologies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Microbiome Sequencing market.
Regional Analysis: The report involves examining the Human Microbiome Sequencing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Microbiome Sequencing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Microbiome Sequencing:
Company Analysis: Report covers individual Human Microbiome Sequencing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Microbiome Sequencing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Genome Analysis, Metabolome Analysis).
Technology Analysis: Report covers specific technologies relevant to Human Microbiome Sequencing. It assesses the current state, advancements, and potential future developments in Human Microbiome Sequencing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Microbiome Sequencing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Microbiome Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Next-Generation Sequencing
Traditional Sequencing Technologies
Other
Market segment by Application
Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis
Market segment by players, this report covers
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Microbiome Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Microbiome Sequencing, with revenue, gross margin and global market share of Human Microbiome Sequencing from 2019 to 2024.
Chapter 3, the Human Microbiome Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Human Microbiome Sequencing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Microbiome Sequencing.
Chapter 13, to describe Human Microbiome Sequencing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Human Microbiome Sequencing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Human Microbiome Sequencing by Type
1.3.1 Overview: Global Human Microbiome Sequencing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Human Microbiome Sequencing Consumption Value Market Share by Type in 2023
1.3.3 Next-Generation Sequencing
1.3.4 Traditional Sequencing Technologies
1.3.5 Other
1.4 Global Human Microbiome Sequencing Market by Application
1.4.1 Overview: Global Human Microbiome Sequencing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Genome Analysis
1.4.3 Metabolome Analysis
1.4.4 Transcriptome Analysis
1.4.5 Other Omics Analysis
1.5 Global Human Microbiome Sequencing Market Size & Forecast
1.6 Global Human Microbiome Sequencing Market Size and Forecast by Region
1.6.1 Global Human Microbiome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Human Microbiome Sequencing Market Size by Region, (2019-2030)
1.6.3 North America Human Microbiome Sequencing Market Size and Prospect (2019-2030)
1.6.4 Europe Human Microbiome Sequencing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Human Microbiome Sequencing Market Size and Prospect (2019-2030)
1.6.6 South America Human Microbiome Sequencing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Human Microbiome Sequencing Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Baseclear B.V.
2.1.1 Baseclear B.V. Details
2.1.2 Baseclear B.V. Major Business
2.1.3 Baseclear B.V. Human Microbiome Sequencing Product and Solutions
2.1.4 Baseclear B.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Baseclear B.V. Recent Developments and Future Plans
2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
2.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Details
2.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Major Business
2.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Product and Solutions
2.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments and Future Plans
2.3 Charles River Laboratories International Inc.
2.3.1 Charles River Laboratories International Inc. Details
2.3.2 Charles River Laboratories International Inc. Major Business
2.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Product and Solutions
2.3.4 Charles River Laboratories International Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Charles River Laboratories International Inc. Recent Developments and Future Plans
2.4 Clinical Microbiomics A/S
2.4.1 Clinical Microbiomics A/S Details
2.4.2 Clinical Microbiomics A/S Major Business
2.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Product and Solutions
2.4.4 Clinical Microbiomics A/S Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Clinical Microbiomics A/S Recent Developments and Future Plans
2.5 Eurofins Scientific SE
2.5.1 Eurofins Scientific SE Details
2.5.2 Eurofins Scientific SE Major Business
2.5.3 Eurofins Scientific SE Human Microbiome Sequencing Product and Solutions
2.5.4 Eurofins Scientific SE Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Eurofins Scientific SE Recent Developments and Future Plans
2.6 GENEWIZ, Inc.
2.6.1 GENEWIZ, Inc. Details
2.6.2 GENEWIZ, Inc. Major Business
2.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Product and Solutions
2.6.4 GENEWIZ, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GENEWIZ, Inc. Recent Developments and Future Plans
2.7 Illumina, Inc.
2.7.1 Illumina, Inc. Details
2.7.2 Illumina, Inc. Major Business
2.7.3 Illumina, Inc. Human Microbiome Sequencing Product and Solutions
2.7.4 Illumina, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Illumina, Inc. Recent Developments and Future Plans
2.8 Novogene Corporation
2.8.1 Novogene Corporation Details
2.8.2 Novogene Corporation Major Business
2.8.3 Novogene Corporation Human Microbiome Sequencing Product and Solutions
2.8.4 Novogene Corporation Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novogene Corporation Recent Developments and Future Plans
2.9 OraSure Technologies, Inc.
2.9.1 OraSure Technologies, Inc. Details
2.9.2 OraSure Technologies, Inc. Major Business
2.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Product and Solutions
2.9.4 OraSure Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 OraSure Technologies, Inc. Recent Developments and Future Plans
2.10 Oxford Nanopore Technologies, Inc.
2.10.1 Oxford Nanopore Technologies, Inc. Details
2.10.2 Oxford Nanopore Technologies, Inc. Major Business
2.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Product and Solutions
2.10.4 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Oxford Nanopore Technologies, Inc. Recent Developments and Future Plans
2.11 Pacific Biosciences of California, Inc.
2.11.1 Pacific Biosciences of California, Inc. Details
2.11.2 Pacific Biosciences of California, Inc. Major Business
2.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Product and Solutions
2.11.4 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Pacific Biosciences of California, Inc. Recent Developments and Future Plans
2.12 QIAGEN N.V.
2.12.1 QIAGEN N.V. Details
2.12.2 QIAGEN N.V. Major Business
2.12.3 QIAGEN N.V. Human Microbiome Sequencing Product and Solutions
2.12.4 QIAGEN N.V. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 QIAGEN N.V. Recent Developments and Future Plans
2.13 Second Genome, Inc.
2.13.1 Second Genome, Inc. Details
2.13.2 Second Genome, Inc. Major Business
2.13.3 Second Genome, Inc. Human Microbiome Sequencing Product and Solutions
2.13.4 Second Genome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Second Genome, Inc. Recent Developments and Future Plans
2.14 Thermo Fisher Scientific Inc.
2.14.1 Thermo Fisher Scientific Inc. Details
2.14.2 Thermo Fisher Scientific Inc. Major Business
2.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Product and Solutions
2.14.4 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.15 Viome, Inc.
2.15.1 Viome, Inc. Details
2.15.2 Viome, Inc. Major Business
2.15.3 Viome, Inc. Human Microbiome Sequencing Product and Solutions
2.15.4 Viome, Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Viome, Inc. Recent Developments and Future Plans
2.16 CosmosID
2.16.1 CosmosID Details
2.16.2 CosmosID Major Business
2.16.3 CosmosID Human Microbiome Sequencing Product and Solutions
2.16.4 CosmosID Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 CosmosID Recent Developments and Future Plans
2.17 Leucine Rich Bio Pvt. Ltd.
2.17.1 Leucine Rich Bio Pvt. Ltd. Details
2.17.2 Leucine Rich Bio Pvt. Ltd. Major Business
2.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Product and Solutions
2.17.4 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Leucine Rich Bio Pvt. Ltd. Recent Developments and Future Plans
2.18 Microba
2.18.1 Microba Details
2.18.2 Microba Major Business
2.18.3 Microba Human Microbiome Sequencing Product and Solutions
2.18.4 Microba Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Microba Recent Developments and Future Plans
2.19 Microbiome Insights Inc.
2.19.1 Microbiome Insights Inc. Details
2.19.2 Microbiome Insights Inc. Major Business
2.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Product and Solutions
2.19.4 Microbiome Insights Inc. Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Microbiome Insights Inc. Recent Developments and Future Plans
2.20 Molzym GmbH & Co. KG
2.20.1 Molzym GmbH & Co. KG Details
2.20.2 Molzym GmbH & Co. KG Major Business
2.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Product and Solutions
2.20.4 Molzym GmbH & Co. KG Human Microbiome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Molzym GmbH & Co. KG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Human Microbiome Sequencing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Human Microbiome Sequencing by Company Revenue
3.2.2 Top 3 Human Microbiome Sequencing Players Market Share in 2023
3.2.3 Top 6 Human Microbiome Sequencing Players Market Share in 2023
3.3 Human Microbiome Sequencing Market: Overall Company Footprint Analysis
3.3.1 Human Microbiome Sequencing Market: Region Footprint
3.3.2 Human Microbiome Sequencing Market: Company Product Type Footprint
3.3.3 Human Microbiome Sequencing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Human Microbiome Sequencing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Human Microbiome Sequencing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Human Microbiome Sequencing Consumption Value Market Share by Application (2019-2024)
5.2 Global Human Microbiome Sequencing Market Forecast by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Sequencing Consumption Value by Type (2019-2030)
6.2 North America Human Microbiome Sequencing Consumption Value by Application (2019-2030)
6.3 North America Human Microbiome Sequencing Market Size by Country
6.3.1 North America Human Microbiome Sequencing Consumption Value by Country (2019-2030)
6.3.2 United States Human Microbiome Sequencing Market Size and Forecast (2019-2030)
6.3.3 Canada Human Microbiome Sequencing Market Size and Forecast (2019-2030)
6.3.4 Mexico Human Microbiome Sequencing Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Human Microbiome Sequencing Consumption Value by Type (2019-2030)
7.2 Europe Human Microbiome Sequencing Consumption Value by Application (2019-2030)
7.3 Europe Human Microbiome Sequencing Market Size by Country
7.3.1 Europe Human Microbiome Sequencing Consumption Value by Country (2019-2030)
7.3.2 Germany Human Microbiome Sequencing Market Size and Forecast (2019-2030)
7.3.3 France Human Microbiome Sequencing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Human Microbiome Sequencing Market Size and Forecast (2019-2030)
7.3.5 Russia Human Microbiome Sequencing Market Size and Forecast (2019-2030)
7.3.6 Italy Human Microbiome Sequencing Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Sequencing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Human Microbiome Sequencing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Human Microbiome Sequencing Market Size by Region
8.3.1 Asia-Pacific Human Microbiome Sequencing Consumption Value by Region (2019-2030)
8.3.2 China Human Microbiome Sequencing Market Size and Forecast (2019-2030)
8.3.3 Japan Human Microbiome Sequencing Market Size and Forecast (2019-2030)
8.3.4 South Korea Human Microbiome Sequencing Market Size and Forecast (2019-2030)
8.3.5 India Human Microbiome Sequencing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Human Microbiome Sequencing Market Size and Forecast (2019-2030)
8.3.7 Australia Human Microbiome Sequencing Market Size and Forecast (2019-2030)
9 South America
9.1 South America Human Microbiome Sequencing Consumption Value by Type (2019-2030)
9.2 South America Human Microbiome Sequencing Consumption Value by Application (2019-2030)
9.3 South America Human Microbiome Sequencing Market Size by Country
9.3.1 South America Human Microbiome Sequencing Consumption Value by Country (2019-2030)
9.3.2 Brazil Human Microbiome Sequencing Market Size and Forecast (2019-2030)
9.3.3 Argentina Human Microbiome Sequencing Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Sequencing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Human Microbiome Sequencing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Human Microbiome Sequencing Market Size by Country
10.3.1 Middle East & Africa Human Microbiome Sequencing Consumption Value by Country (2019-2030)
10.3.2 Turkey Human Microbiome Sequencing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Human Microbiome Sequencing Market Size and Forecast (2019-2030)
10.3.4 UAE Human Microbiome Sequencing Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Human Microbiome Sequencing Market Drivers
11.2 Human Microbiome Sequencing Market Restraints
11.3 Human Microbiome Sequencing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Human Microbiome Sequencing Industry Chain
12.2 Human Microbiome Sequencing Upstream Analysis
12.3 Human Microbiome Sequencing Midstream Analysis
12.4 Human Microbiome Sequencing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG
听
听
*If Applicable.
